At the 78th World Health Assembly (WHA78), Member States unanimously adopted the Integrated Lung Health Resolution. This is the first comprehensive commitment by the World Health Organization (WHO) to cover a broad spectrum of respiratory diseases.
The resolution emphasizes the need for a comprehensive approach to lung diseases, encompassing both communicable and non-communicable diseases – from tuberculosis and pneumonia, through COPD and asthma, to lung cancer.
The resolution identifies four main pillars for an effective lung health strategy:
- prevention (including vaccinations, combating air pollution, tobacco control),
- diagnostics and early detection of respiratory diseases,
- access to treatment and medical technologies,
- strengthening primary health care with lung health as an integral part of it.
The adopted document calls on WHO member states to:
- create a national health policy framework integrated around lung health,
- implement effective prevention and treatment pathways within primary health care,
- develop clinical guidelines, including for COPD and lung cancer,
- improve access to essential medicines and therapeutic technologies. At the same time, the resolution obliges
WHO to prepare a report by 2027, containing specific recommendations for member states on the implementation of an integrated lung health policy.
https://iris.who.int/bitstream/handle/10665/380840/9789240107526-eng.pdf?sequence=1
Latest news
New GINA
The new GINA has already been published – a document necessary for every doctor dealing with asthma. We invite you to read this study at https://ginasthma.org/2024-report/
VIII Congress Patient Empowerment
The 8th Patient Empowerment Congress takes place on May 14-15 under the patronage of the Polish Society of Allergology in Warsaw. This is an event
World Asthma Day 2024
We invite you to actively participate in the celebration of World Asthma Day 2024! Workshops for journalists “Education in asthma – an essential element of
Anna Ben Drissi is a finalist of the MedWoman 2023 competition
This time, we are pleased to announce that Anna Ben Drissi, managing director of the Polish Society of Allergology and coordinator of the Asthma Treatment